Würk, National Crime Search Partner to Streamline Background Checks for Cannabis Industry
August 5, 2025
US Hemp Roundtable Applauds Senate for Passing Bill Without Harmful Hemp Ban
August 5, 2025
[PRESS RELEASE] – SMITHS FALLS, Ontario, Aug. 5, 2025 – Canopy Growth Corp., a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has introduced its Canadian-grown 7ACRES brand in Australia, expanding the company’s medical cannabis offering with two high-THC sativa strains: Ultra Jack and Jack Frost.
Ultra Jack, a cross of Ultra Sour and Jack Haze, is one of 7ACRES’ top-performing flower strains in the Canadian medical and adult-use cannabis markets. Jack Frost, a cross of White Widow and Cold Creek Kush, adds further genetic depth to the lineup. Both strains are initially available in 10-gram flower formats.
“Adding 7ACRES to our Australian portfolio helps ensure patients and prescribers have access to a diverse range of high-quality flower options,” said Andrew Bevan, senior vice president, Global Medical. “With recent improvements to our global supply chain, we’re positioned to deliver these strains with consistent quality and reliable access to patients in Australia.”
“Global medical is one of Canopy Growth’s largest commercial opportunities,” CEO Luc Mongeau said. “Our ability to scale high-quality production in Canada and reliably supply international markets remains a key strength as we expand our global medical platform.”
The introduction of 7ACRES complements Canopy Growth’s existing presence in Australia, which includes Tweed flower products as well as Spectrum Therapeutics oils available in Red, Yellow, White and Blue formulations. Together, this expanded medical portfolio reflects Canopy Growth’s focus on building a scalable medical platform across international markets.
